首页> Bioorganic chemistry> A calmodulin-derived peptide TI-16 inhibits Alzheimer's disease progression by decreasing -Aβ burden and restoring calcium dyshomeostasis.

A calmodulin-derived peptide TI-16 inhibits Alzheimer's disease progression by decreasing -Aβ burden and restoring calcium dyshomeostasis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jingyang,Su

第一单位： Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang 110122, China; Department of Clinical Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China.

作者： Jingyang,Su ^[1] ; Jun,Wei ^[2] ; Bowen,Zhang ^[2] ; Xianghui,Wang ^[2] ; Luhong,Tang ^[3] ; Yuan,Yuan ^[2] ; Xuanxuan,Sun ^[2] ; Shuang,Qi ^[2] ; Jiaoyan,Yang ^[3] ; Yingchun,Xue ^[2] ; Yalin,Liu ^[2] ; Yifang,Liu ^[3] ; Xuefei,Sun ^[2] ; Liying,Hao ^[4]

作者单位： Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang 110122, China; Department of Clinical Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China. ^[1] Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang 110122, China. ^[2] Department of Clinical Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China. ^[3] Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang 110122, China. Electronic address: lyhao@cmu.edu.cn. ^[4]

关键词 Alzheimer's disease Amyloid-β Ca(2+) homeostasis Innovative peptide Targeted therapy